Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma

NCT01455363 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institut Curie